RNAi-mediated Gene Silencing of Mutant Myotilin Improves Myopathy in LGMD1A Mice

Recent progress suggests gene therapy may one day be an option for treating some forms of limb girdle muscular dystrophy (LGMD). Nevertheless, approaches targeting LGMD have so far focused on gene replacement strategies for recessive forms of the disease. In contrast, no attempts have been made to d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Liu, Jian, Wallace, Lindsay M, Garwick-Coppens, Sara E, Sloboda, Darcée D, Davis, Carol S, Hakim, Chady H, Hauser, Michael A, Brooks, Susan V, Mendell, Jerry R, Harper, Scott Q
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group 2014
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4013433/
https://ncbi.nlm.nih.gov/pubmed/24781192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2014.13
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge